About US

Greetings from the CEO

Greetings from the CEO

Living bodies are made of highly delicate mechanisms. In my 30 years of working in research, I have learnt that “living organisms know best about living organisms”. This is also true in drug discovery, and direct screening in animals allows substances with efficacy to be obtained from the first attempt. However, we previously did not have the methods available to achieve this. This was the background in which Sky Pharma’s drug discovery pipeline was developed.

Profile

CEO: Hideki Ando Ph.D.

  • Affiliate Professor, Tohoku University Graduate School of Dentistry (in office)
  • Associate Professor, Department of Medicine, Tokyo Medical University
  • Project Associate Professor, Department of Life Science and Technology, Tokyo Institute of Technology
  • Research Fellow, Brain Science Institute, Institute of Physical and Chemical Research (RIKEN)
  • Assistant Professor, The University of Tokyo, Department of Medicine

Company Overview

Company name Sky Pharma Co., Ltd.
CEO (Founder) Hideki Ando, Ph.D.
Address [Main Office]
Higashinihon Fudosan Sendai First Bldg. 1F, 6-1, Shimizukoji, Wakabayashi-ku, Sendai City, Miyagi, 984-0075, Japan
[1st Laboratory]
Division of Oral Physiology, Department of Oral Function and Morphology, Tohoku University Graduate School of Dentistry. 4-1 Seiryo-machi, Aoba-ku, Sendai City, Miyagi, 980-8575, Japan
[2nd Laboratory]
Room 206, Tohoku University Cooperation Business Incubator (T-Biz), 6-6-40 Aoba, Aramaki, Aoba-ku, Sendai City, Miyagi, 980-8579, Japan
Phone +81-22-398-6635
Capital Stock 57,000,000 JPY
Major Shareholders MAKOTO Capital Co., Ltd.
Digisearch and Advertising Inc.
Minato Mirai Patent Firm
Business Details Development of regenerative medicine products
Patent application Japan Patent Application No. 2020-063994* [Title] Regenerative medicine for the nervous system
Japan Patent Application No. 2020-063994* [Title] Regenerative medicine for the nervous system
Japan Patent Application No. 2020-063996* [Title] Regenerative medicine for the nervous system
Japan Patent Application No. 2020-063997* [Title] Screening method and manufacturing method for regenerative medicine of the nervous system
WO 2021/201170 [Title] Method for screening for, method for producing, and method for designing drug active ingredients
https://patentscope.wipo.int/search/ja/detail.jsf?docId=WO2021201170&tab=PCTBIBLIO
*Basis for an International application with a claim to priority under the Treaty of Paris.

Address

1st Laboratory

2nd Laboratory

Collaboration and
Partnership

Inquiries

Contact the number below for inquiries regarding collaboration and partnership with Sky Pharma Co.,Ltd.

TEL 022-398-6635

Phone +81-22-398-6635

Inquiries Regarding Collaboration and Partnership

Businesses and
Products

Inquiries

Contact the number below for inquiries regarding the businesses and products of Sky Pharma Co.,Ltd.

TEL 022-398-6635

Phone +81-22-398-6635

Inquiries Regarding Our Businesses and Products